Bioscience
Engineering lab at CSU transformed into testing site for COVID-19 medical protective gear
FORT COLLINS -- Professor John Volckens 2,000-square-foot lab on the campus of Colorado State University is normally a place for experiments on air quality, pollution sensors, and how breathable... Read More
Tuesday April 7, 2020 0 comments
CSU researchers pursue a vaccine to target Achilles heel of coronavirus
FORT COLLINS -- Propelled by the COVID-19 pandemic, a Colorado State University research team is pursuing a vaccine that would thwart the novel coronavirus using a genetically... Read More
Monday April 6, 2020 0 comments
Ampio Pharmaceutical's FDA application for Ampion clinical study to treat COVID-19 ARDS on TV
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it was featured on aFOXTV segment titled, "Englewoodpharmaceutical company looking to treat COVID-19 patients with... Read More
Friday April 3, 2020 0 comments
Aytu BioScience gets FDA approval to begin distribution of COVID-19 rapid tests across U.S.
ENGLEWOOD -- Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced it has received... Read More
Thursday March 26, 2020 0 comments
CSU to lead testing qualification for protective masks in COVID-19 fight
FORT COLLINS -- Colorado State University has been asked by Gov. Jared Polis and the State of Colorado to organize testing of personal protective equipment (PPE) to protect... Read More
Thursday March 26, 2020 0 comments
CSU engineers, disease researchers moving quickly on a disinfectant against COVID-19
FORT COLLINS -- Across Colorado State Universitys campus, most research operations have gone quiet in the wake of COVID-19 pandemic restrictions. But theres one lab at the Energy... Read More
Wednesday March 25, 2020 0 comments
Cell>Point to expedite research on new drugs as potentially effective theranostic technology in fight against COVID-19
CENTENNIAL -- CellPoint announced plans to move forward with a research program to clinically develop 99m Tc-EC-Amifostine and 177 Lu-EC-Amifostine to assess, treat and follow-up with confirmatory... Read More
Wednesday March 25, 2020 0 comments
Ampio prepares FDA protocol to study Ampion as treatment for COVID-19 Acute Respiratory Distress
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it is preparing an expanded access FDA protocolto study potential benefit of nebulized treatment with Ampion in SARS-Cov-2... Read More
Wednesday March 25, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
